Qlucore participates at Redeye Theme Digital Health
Qlucore participates at Redeye Theme Digital Health Day March 31st.
Qlucore, listed on Nasdaq First North, participates on Redeye Theme Digital Health Day. CEO, Carl-Johan Ivarsson, presents the company at 09:30 and participates in the panel afterwards.
Qlucore’s software creates possibilities for improved cancer care. This is possible through advanced visualization, built on mathematics and biology, which makes it easier for analysts and pathologists to determine faster and more precise diagnoses.
Redeye performs researched powered investment banking with a belief that Scandinavia will be a hub spot for the major future innovations within tech and life science.
The presentation is live broadcasted and can be followed at https://www.redeye.se/events/830579/redeye-theme-digital-health-day where the presentations will be available afterwards.
About Qlucore
Qlucore is a leading provider of new generation intuitive bioinformatics software for research and precision and companion diagnostics. Qlucore’s mission is to make it easier to analyze the huge amounts of complex data generated by innovations in the fields of genomics and proteomics by providing powerful visualization-based bioinformatics data analysis tools for research and precision diagnostics. Qlucore Omics Explorer software is a Do-It-Yourself bioinformatics software for research in the life science, plant- and biotech industries, as well as academia. Qlucore Diagnostics and Qlucore Insights are software platforms with built in AI-based machine learning for multi-omics companion and precision diagnostics. Qlucore was founded in 2007 in Lund, Sweden and has customers in about 25 countries around the world, with sales offices in Europe and North America, and distribution in several countries in Asia. Qlucore is listed on the Nasdaq First North Growth market. www.qlucore.com